- Home
- MRK vs TXN Comparison
MRK vs TXN Comparison
Compare MRK & TXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | TXN |
|---|---|---|
| Founded | 2000 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 256.7B |
| IPO Year | 1994 | 2002 |
Fundamental Metrics
Financial Performance| Metric | MRK | TXN |
|---|---|---|
| Price | $126.26 | $301.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 25 |
| Target Price | $125.59 | ★ $265.46 |
| AVG Volume (30 Days) | 8.2M | ★ 8.7M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.06% | 2.11% |
| EPS Growth | ★ 8.01 | 4.81 |
| EPS | N/A | ★ 1.68 |
| Revenue | ★ $65,011,000,000.00 | $17,682,000,000.00 |
| Revenue This Year | $3.61 | $11.74 |
| Revenue Next Year | $5.41 | $10.43 |
| P/E Ratio | ★ N/A | $179.51 |
| Revenue Growth | 1.31 | ★ 13.05 |
| 52 Week Low | $76.66 | $152.73 |
| 52 Week High | $130.29 | $334.03 |
Technical Indicators
Market Signals| Indicator | MRK | TXN |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 54.70 |
| Support Level | $112.68 | $274.83 |
| Resistance Level | $130.29 | $310.29 |
| Average True Range (ATR) | 3.19 | 12.61 |
| MACD | 0.19 | -0.58 |
| Stochastic Oscillator | 73.18 | 59.02 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.